BlackRock Institutional Trust’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-65,386
Closed -$30K 4010
2016
Q2
$30K Sell
65,386
-42,871
-40% -$68.8K ﹤0.01% 3793
2016
Q1
$291K Sell
108,257
-19,584
-15% -$55K ﹤0.01% 3555
2015
Q4
$395K Buy
127,841
+70,491
+123% +$318K ﹤0.01% 3546
2015
Q3
$253K Sell
57,350
-51,795
-47% -$304K ﹤0.01% 3610
2015
Q2
$623K Buy
109,145
+5,918
+6% +$40.4K ﹤0.01% 3463
2015
Q1
$924K Buy
+103,227
New +$829K ﹤0.01% 3365

Other funds holding EPRS

BlackRock Institutional Trust's EPRS Position: Q3 2016 in Review

BlackRock Institutional Trust sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 65,386 shares — an estimated $30K sold.

BlackRock Institutional Trust first reported a position in EPRS in Q1 2015 and held it in 6 quarters. The position peaked at $924K in Q1 2015. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

  • BlackRock Institutional Trust reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
  • BlackRock Institutional Trust sold 65,386 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016, an estimated $30K.
  • BlackRock Institutional Trust first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q1 2015 and held it in 6 quarters.
  • BlackRock Institutional Trust's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $924K in Q1 2015.
  • 3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on BlackRock Institutional Trust's 13F filing for Q3 2016, filed 8 Nov 2016.